The only difference is salt: 0 vs 308 mOsm/L. Compare USP composition, benzyl alcohol preservation, sterility after puncture, and when each diluent fits.
Bacteriostatic water and bacteriostatic saline differ by exactly one ingredient: salt. Bacteriostatic Water for Injection USP is purified water plus 0.9% w/v benzyl alcohol (9 mg/mL) as a bacteriostatic agent, with an osmolarity of essentially 0 mOsm/L. Bacteriostatic 0.9% Sodium Chloride Injection USP is the same benzyl alcohol system carried in isotonic saline — 9 mg/mL sodium chloride, roughly 154 mmol/L each of sodium and chloride, about 308 mOsm/L. Both are preserved, multi-puncture diluents. Neither is sterile after the closure is first breached; the benzyl alcohol only inhibits bacterial growth, it does not sterilize. For a laboratory buying reference materials, the salt is not a trivial difference — it changes ionic strength, solubility behavior, and what happens when the solution hits a mass spectrometer.
Strip away the marketing and there are four variables that distinguish these products on a certificate or a package insert:
Endotoxin and particulate specifications track the USP injection monographs: bacterial endotoxins typically controlled at less than 0.25 EU/mL for the water component, and particulate matter under USP <788> for small-volume injections at no more than 6,000 particles ≥10 µm and 600 particles ≥25 µm per container. Those numbers are worth citing back to a supplier who claims "lab grade" without naming a compendial standard.
Ionic strength is the practical reason to care. A 154 mM chloride solution has an ionic strength near 0.154 M; purified water sits near zero. That gap drives three measurable behaviors in peptide and small-molecule reference material work.
Solubility is the first. Many peptides show salting-in behavior at low ionic strength and reduced solubility as ionic strength climbs, particularly near their isoelectric point. A material with a pI close to the solution pH can visibly haze in saline while staying clear in unsalted water. Second is aggregation kinetics: charge screening by chloride reduces electrostatic repulsion between like-charged monomers, and for aggregation-prone sequences that shortens the window before you see particulates by light obscuration or dynamic light scattering. Third is freezing behavior — 0.9% saline depresses the freezing point to about −0.52 °C, which is irrelevant at room temperature and very relevant if a shipment sits on a loading dock in January.
The benzyl alcohol is a growth inhibitor, not a sterilant. A container that has been punctured twenty times is a preserved container, not a sterile one, and no amount of preservative retroactively makes it one.
This is the part most comparison pages skip entirely, and it is the part that costs real money.
Sodium chloride is non-volatile. Introduce it to an electrospray source and you get three problems at once: ion suppression that flattens your signal, sodium adduct formation that shifts the observed mass by +21.982 Da relative to the protonated species, and salt deposition on the sampling cone and capillary that forces source cleaning far ahead of schedule. A lab running direct-injection LC-MS on a salted matrix can turn a 1,000-injection column into a 300-injection column and add an unscheduled source teardown every few weeks. Desalting steps recover the situation but typically cost 10–20% sample recovery and add handling time per sample.
Benzyl alcohol causes a separate problem that affects both products equally. It is an aromatic chromophore. It absorbs strongly in the far UV and carries measurable absorbance up through the 250–260 nm region — squarely on top of the 214 nm and 220 nm peptide bond detection wavelengths used in reversed-phase HPLC. On a gradient run it elutes early and can bury anything with a short retention time. If quantitation at 214 nm is the analytical endpoint, a preserved diluent is a poor choice regardless of whether it contains salt.
Expect an asymmetry here that suppliers rarely explain up front. A lyophilized reference material should come with a full certificate of analysis — HPLC purity, mass spectrometric identity confirmation, water content, and a lot number that traces to a specific synthesis. Our approach to that documentation is described on the quality page.
A diluent is a different document class. What you should be able to obtain:
What you will generally not get is a per-lot HPLC chromatogram, because that is not how compendial diluents are released. A supplier who offers you a peptide-style COA for a bottle of saline is either confused or generating documents. Verify the lot against the manufacturer, not the reseller.
Unopened, both products typically carry 24 to 36 months of dating from manufacture. Neither requires refrigeration; both ship ambient, which keeps freight costs closer to $8–$15 than to the $40–$70 typical of a cold-chain shipment. Details of how we handle ambient and cold-chain consignments are on the shipping page.
Once a multi-puncture closure has been entered, the governing figure most laboratories apply is the 28-day in-use period assigned to preserved multi-dose containers, which is why the benzyl alcohol is there at all. A single-use, unpreserved sterile water ampoule has no such window — it is a single-entry container. Two practical consequences: a 30 mL vial punctured on day 1 and discarded on day 29 has an effective cost measured against 28 days regardless of volume remaining, and a lab drawing three samples per year is throwing away 90% of what it buys.
Street pricing runs roughly $12–$25 for a 30 mL vial of bacteriostatic water at retail, and about $2–$5 more for the saline equivalent, since sodium chloride injection carries a slightly higher manufacturing and monograph burden. At case quantities — typically 25 vials — the per-unit figure commonly falls to $6–$10. That is a 40–60% reduction, and it is why case buying looks obvious. See wholesale for volume structure.
The leak is expiry. A case of 25 vials at $8 each is $200. A lab that consumes four vials a year and lets the remaining 21 expire at 30 months has paid $200 for roughly $32 of used material — an effective cost of $50 per vial actually consumed, four to six times the sticker price. Case pricing only wins if annual consumption is above roughly 10–12 vials.
This is the section that costs us a sale, so here it is plainly.
One more limitation worth stating: benzyl alcohol is bacteriostatic, not sporicidal and not reliably fungicidal across the board. It suppresses vegetative bacterial growth. It does not address bacterial spores, and it does nothing about particulates or endotoxin already present. A preserved diluent is a hedge against slow contamination in a repeatedly-entered container, not a substitute for aseptic technique or for a properly qualified source.
If ionic strength is irrelevant to the material and downstream analysis is not salt-sensitive, bacteriostatic water is the cheaper and analytically cleaner of the two. If the protocol specifies an isotonic carrier for a defined reason — a documented solubility or stability requirement in the material's own literature — bacteriostatic saline is the correct purchase and the extra $2–$5 per vial is not worth arguing about. What is not defensible is choosing based on which one a forum post recommended.
All materials discussed here are supplied for laboratory research use only; see research use only and the disclaimer. Purity and identity documentation for individual reference materials is indexed in the library, and specific lot questions go through contact.
Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.
Purity, identity and lot number, documented for the exact vial you receive.